Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: A phase i randomized, controlled, dose-escalation study
Michelle Petri, Daniel J. Wallace, Alberto Spindler, Vishala Chindalore, Kenneth Kalunian, Eduardo Mysler, C. Michael Neuwelt, Gabriel Robbie, Wendy I. White, Brandon W. Higgs, Yihong Yao, Liangwei Wang, Warren Greth
Dive into the research topics of 'Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: A phase i randomized, controlled, dose-escalation study'. Together they form a unique fingerprint.